Related Experiment Video

Updated: Jul 17, 2026

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli
08:01

A Method for Manipulating Blood Glucose and Measuring Resulting Changes in Cognitive Accessibility of Target Stimuli

Published on: August 12, 2016

Web Sites that Address Gestational Diabetes and Perinatal Obesity

Kristen S Montgomery1

  • 1K risten M ontgomery is a postdoctoral research fellow in the School of Nursing at the University of Michigan in Ann Arbor, Michigan.

The Journal of Perinatal Education
|February 3, 2007
PubMed

Insights

Obesity during pregnancy increases health risks and the likelihood of developing gestational diabetes. This review highlights top online resources for managing obesity and gestational diabetes in the perinatal period.

Area of Science:

  • Reproductive Health
  • Endocrinology
  • Public Health

Background:

  • Obesity is a significant risk factor for adverse pregnancy outcomes.
  • Obesity during pregnancy is linked to an increased incidence of gestational diabetes mellitus (GDM).
  • Gestational diabetes poses risks to both maternal and fetal health.

Purpose of the Study:

  • To identify and review the best currently available web resources.
  • To provide guidance for pregnant individuals and healthcare providers on managing GDM and obesity.
  • To enhance accessibility to reliable information on perinatal health and metabolic disorders.

Main Methods:

  • Systematic review of online resources.
  • Evaluation of web content for accuracy, relevance, and accessibility.
  • Identification of key themes and information provided by top-rated websites.

Main Results:

  • Several high-quality websites offer comprehensive information on GDM and pregnancy obesity.
  • Resources cover topics such as nutrition, exercise, monitoring, and treatment options.
  • Effective online resources empower patients with knowledge for better self-management.

Conclusions:

  • Accessible online resources are crucial for supporting women with gestational diabetes and obesity.
  • Healthcare providers should direct patients to evidence-based online information.
  • Improved access to information can lead to better management of GDM and associated maternal obesity.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Diabetes Mellitus: Introduction01:26

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...